ReviewInternational journal of clinical pharmacy2011
Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
Review in International journal of clinical pharmacy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Reviewing the literature, how systematic is systematic?International journal of clinical pharmacy · 2016Pooled it
- Do educational meetings and group detailing change adherence to drug formularies in hospitals? A cluster randomized controlled trial.European journal of clinical pharmacology · 2014Trial
- Promoting Sustainable Prescribing-A Case Study Presenting Experiences From Two Swedish Drug and Therapeutics Committees.Pharmacology research & perspectives · 2026Article
- Article
- A Formulary Management Group Consensus.Global journal on quality and safety in healthcare · 2024Article
- Article
- Drug and therapeutics committee interventions in managing irrational drug use and antimicrobial stewardship in China.Frontiers in pharmacology · 2022Article
- Personal Formularies of Primary Care Physicians Across 4 Health Care Systems.JAMA network open · 2021Article
- Drug and Therapeutics Committee (DTC) evolvement and expanded scope in Ethiopia.Gates open research · 2021Article
- Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province.Frontiers in pharmacology · 2020Article
- Impact of removal and restriction of me-too medicines in a hospital drug formulary on in- and outpatient drug prescriptions: interrupted time series design with comparison group.Implementation science : IS · 2019Article
- Potential Cost-Savings with Once-Daily Aminomethylcycline Antibiotic versus Vancomycin in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections.American health & drug benefits · 2018Article
- A P&T Committee's Transition to a Complete Electronic Meeting System-A Multisite Institution Experience.P & T : a peer-reviewed journal for formulary management · 2017Article
- Factors associated with prescribing restriction on oncology formulary drugs in Malaysia.International journal of clinical pharmacy · 2016Article
- Ability and Use of Comparative Effectiveness Research by P&T Committee Members and Support Staff: A 1-Year Follow-up.Journal of managed care & specialty pharmacy · 2016Article
- Challenges of medicines management in the public and private sector under Ghana's National Health Insurance Scheme - A qualitative study.Journal of pharmaceutical policy and practice · 2016Article
- The evolution of Reference Drug Lists and Clinical Practice Guidelines in the public health system of a middle-income country.British journal of clinical pharmacology · 2014Article
- Drug assessment by a Pharmacy and Therapeutics committee: from drug selection criteria to use in clinical practice.Therapeutics and clinical risk management · 2014Article
- Adherence to hospital drug formularies and cost of drugs in hospitals in Denmark.European journal of clinical pharmacology · 2013Article
- The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees.European journal of clinical pharmacology · 2013Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aim of the reviewTo review the literature on the structure and operation of hospital Pharmacy and Therapeutics Committees from an international point of view and examine the factors that influence decision-making of these committees.
methodWe performed a literature search in the Medline and Embase databases from 1997 to January 2009 with the search terms: formulary system decision making, pharmacy and therapeutics committee, formularies hospital, drug formulary, survey, drug selection and outcome assessment health care. Inclusion criteria were the following: studies analyzing Pharmacy and Therapeutics Committees published in English or Spanish from 1997 to January 2009. Exclusion criteria were: publications which were editorials or opinion pieces, studies relating to one hospital, and studies where full text could not be attained. The analysis was divided into structural/organizational data and data on factors affecting the decision-making process.
resultsSeventeen studies met the inclusion criteria. Pharmacy and Therapeutics Committees and formularies were present in more than 90% of the hospitals in four of the five countries examined. Therapeutic interchange programs existed only in two of these countries. The mean number of committee members ranged between six and eight. More than 89% of the committees included a pharmacist. Standard operating procedures were implemented by 89% of the committees. The most influential factors in the decision-making were clinical trial results or drug costs rather than pharmacoeconomic studies. Other local organization-dependent factors were also important.
conclusionsThe structure and operating procedures of Hospital Pharmacy and Therapeutics Committees are similar in select Western countries. Information from clinical trials is the most influential factor in the decision-making process.
Indexed as
Identifiers
21416393What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.